IRIS
FICORELLA, Corrado
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.303
EU - Europa 4.202
AS - Asia 2.095
OC - Oceania 10
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 8
AF - Africa 5
Totale 13.632
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.286
IE - Irlanda 1.507
CN - Cina 1.001
TR - Turchia 726
DE - Germania 529
SE - Svezia 520
UA - Ucraina 431
IT - Italia 425
GB - Regno Unito 313
SG - Singapore 254
FI - Finlandia 171
FR - Francia 121
CZ - Repubblica Ceca 78
IN - India 43
VN - Vietnam 37
BE - Belgio 36
RU - Federazione Russa 18
CA - Canada 12
AU - Australia 9
EU - Europa 8
RO - Romania 8
KR - Corea 7
IL - Israele 6
NL - Olanda 6
BG - Bulgaria 5
ES - Italia 5
RS - Serbia 5
JP - Giappone 4
TH - Thailandia 4
CH - Svizzera 3
ID - Indonesia 3
MX - Messico 3
PL - Polonia 3
PT - Portogallo 3
AR - Argentina 2
AT - Austria 2
BR - Brasile 2
CL - Cile 2
DM - Dominica 2
EE - Estonia 2
NO - Norvegia 2
ZA - Sudafrica 2
AM - Armenia 1
BF - Burkina Faso 1
BO - Bolivia 1
CO - Colombia 1
CY - Cipro 1
DK - Danimarca 1
EG - Egitto 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MC - Monaco 1
MD - Moldavia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 13.632
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.682
Chandler 1.617
Dublin 1.507
Boardman 529
Izmir 359
Wilmington 292
Nanjing 279
Princeton 240
Lawrence 239
Ann Arbor 235
San Mateo 224
New York 199
Ashburn 188
Singapore 167
Beijing 136
Nanchang 98
Milan 87
Bremen 77
Seattle 76
Brno 75
Shenyang 64
Des Moines 58
Woodbridge 58
Dearborn 55
Tianjin 53
Verona 50
L'aquila 49
Hebei 44
Los Angeles 41
Munich 41
Brussels 36
Kunming 35
Dong Ket 34
Jinan 31
Jiaxing 30
Norwalk 30
Helsinki 28
Dallas 27
Hangzhou 27
Zhengzhou 25
Philadelphia 24
Changsha 21
Mountain View 20
Pune 19
Aquila 17
Ningbo 17
Guangzhou 16
Falls Church 14
Auburn Hills 12
Berlin 12
Fremont 12
London 12
Rome 12
Düsseldorf 11
Lanzhou 11
Redwood City 11
Taizhou 11
Changchun 10
Houston 10
Monza 10
Shanghai 10
Fuzhou 9
Hefei 9
L’Aquila 9
San Francisco 7
Tappahannock 7
Edinburgh 5
Frankfurt am Main 5
Pescara 5
Stockholm 5
Sydney 5
Grafing 4
Orange 4
Phoenix 4
Sofia 4
Washington 4
Caserta 3
Chengdu 3
Ciampino 3
Hanoi 3
Kitzingen 3
Madrid 3
Olomouc 3
Qingdao 3
Seveso 3
Songkhla 3
Teramo 3
Toronto 3
Venezia 3
Zurich 3
Amsterdam 2
Atlanta 2
Baotou 2
Birmingham 2
Bucharest 2
Campobasso 2
Canberra 2
Castellucchio 2
Catanzaro 2
Cedar Knolls 2
Totale 9.562
Salva come PNG Salva come JPEG
Nome #
Breast cancer and psychological resilience among young women 197
Emotional Impact of Breast Cancer Treatment: cross-sectional study on level of anxiety, anger, psychological distress and depression in 2-years perspective 122
P16 hypermethylation contributes to the characterization of gene inactivation profiles in primary gastric cancer 109
The prevalent KRAS exon 2 c.35 G > A mutation in metastatic colorectal cancer patients: a biomarker of worse prognosis and potential benefit of bevacizumab-containing intensive regimens? 103
KRAS and Two Rare PI3KCA Mutations Coexisting in a Metastatic Colorectal Cancer Patient With Aggressive and Resistant Disease. 101
Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis. 100
Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines 99
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations. 99
Dose-finding study of oxaliplatin associated to capecitabine based preoperative chemoradiotherapy in locally advanced rectal cancer 94
Efficacy of pregabalin in the management of cetuximab-related itch 93
Predictive Features of Resilience in Early Breast Cancer Young Patients: experience in Real Life 93
Bioclinical parameters driving decision-making of subsequent lines of treatment in metastatic castration-resistant prostate cancer 90
"Vessels in the Storm": Searching for Prognostic and Predictive Angiogenic Factors in Colorectal Cancer 89
Does pain intensity predict a poor opioid response in cancer patients? 88
Bone targeted therapy for preventing skeletal-related events in metastatic breast cancer 87
Apoptosis induced by oxaliplatin in human colon cancer HCT15 cell line 86
Epigenetic modulation of PTEN expression during antiandrogenic therapies in human prostate cancer 85
Assessment and treatment of symptoms among italian medical oncologists 83
New schedule of bevacizumab/paclitaxel as first-line therapy for metastatic HER2-negative breast cancer in a real-life setting 83
The supportive care task force at the University of L'Aquila: 2-years experience 82
Dose-dense nonpegylated liposomal doxorubicin and docetaxel combination in breast cancer: Dose-finding study 82
Integrating oncology and palliative home care in Italy: the experience of the "L'Aquila per la Vita" Home Care Unit 82
Pain evaluation and management: a survey of Italian radiotherapists 81
two simulteneous and very uncommom pi3kca mutations in a liver metastasis from colorectal cancer patient with aggressive and resistant disease 81
ABERRANT HYPERMETHYLATION OF THE P16 GENE IN SPORADIC GASTRIC CANCER 79
Gabapentin in the treatment of hiccups in patients with advanced cancer: a 5-year experience 79
Cerebral metastasis from ovarian cancer treated with a multidisciplinary approach. Case report and review of literature 77
Oncology together for L'Aquila: early resumption of integrated oncological activities after the earthquake 77
NEW MUTATIONS AND PROTEIC VARIANTS OF NBS1 ARE IDENTIFIED IN CANCER CELL LINES 76
Palliative care in advanced cancer patients: how and when? And where? 76
Tapentadol in cancer pain management: a prospective open-label study 76
Psychological impact of clinical treatment after breast cancer diagnosis in younger patients (38–50 age range): An explorative 3-year observational study 76
Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids 74
Low morphine doses in opioid-naive cancer patients with pain 74
A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer 74
Colorectal cancer (Duke's group B2,C1,C2): adjuvant chemotherapy and toxicity 74
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management 74
Efficacy and safety of deep, continuous palliative sedation at home: A retrospective, single-institution study 73
Biological Function of Oncogenic KRAS In Promoting Angiogenesis 73
Multicentric retrospective analysis of platinum-pemetrexed regimens as first-line therapy in non-squamous non-small cell lung cancer patients: A "snapshot" from clinical practice 73
Hiccup in patients with advanced cancer successfully treated with gabapentin: report of three cases 73
Poker association of weekly alternating 5-fluorouracil, irinotecan,bevacizumab and oxaliplatin (FIrB/FOx) in first line treatment of metastatic colorectal cancer: a phase II study 72
Switching from Transdermal Drugs: An Observational "N of 1" Study of Fentanyl and Buprenorphine 72
Antitumor effects of carnertinib in castration resistant prostate cancer models: A Comparative study with erlotinib. 72
Meccanismo d’azione e farmacologia di nuovi composti organometallici nel trattamento del carcinoma del colon-retto. 71
Worse prognosis of KRAS c.35 G > A mutant metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx). 71
Studies on chemically induced neoplastic transformation and mutation in the BALB/3T3 C1 A31-1-1 cell line in relation to the quantitative evaluation of carcinogens 70
Can malignant bowel obstruction in advanced cancer patients be treated at home ? 70
Gabapentin in the treatment of severe sweating experienced by advanced cancer patients 70
Multidisciplinary management of hepatocellular carcinoma in clinical practice 70
Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay 69
Effects of EGFR tyrosine kinase inhibitor erlotinib in prostate cancer cells in vitro 69
Modulation of GemOx chemotherapy according to CIRS in elderly patients with advanced pancreatic cancer 69
Novel P53 mutations detected by FAMA in colorectal cancers 68
Effective analgesic score: a "marker" of the effects of chemotherapy on pain in advanced cancer patients? 68
Prognostic relevance of PIK3CA mutations in breast cancer patients treated with primary dose-dense epirubicin/cyclophosphamide -> dose-dense docetaxel 68
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 68
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: An insight from clinical practice 68
Combined targeting of epidermal growth factor receptor and MDM2 by gefitinib and antisense MDM2 cooperatively inhibit hormone-independent prostate cancer 68
Acupuncture in the treatment of menopause-related symptoms in women taking tamoxifene 67
Treatment of hepatic metastases from colo-rectal tumors: intra-arterial loco-regional therapy 67
Oncologia Clinica 67
The use of fentanyl buccal tablets for breakthrough pain by using doses proportional to opioid basal regimen in a home care setting 67
Can analysis of the molecular status of the p53 gene contribute to improving the therapeutic strategy for breast carcinoma? 67
Morphine in the treatment of incident pain triggered by vinorelbine infusion 66
Medical emergencies in oncology: hypercalcemia. II. Diagnosisand therapy 66
The adjuvant therapy of colonic carcinoma in old age 66
Prognosis of gastric cancer by p53 gene mutations from "touch preparations" and PCR/SSCP analysis. 66
Effectiveness of liver metastasectomies in patients with metastatic colorectal cancer treated with FIr-B/FOx triplet chemotherapy plus bevacizumab. 66
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study 66
Low doses of transdermal fentanyl in opioid-naive patients with cancer pain 66
Carcinoma of the breast in men 65
Familial ovarian cancer: a study of 11 families 65
Triplet Chemotherapy in Patients With Metastatic Colorectal Cancer: Toward the Best Way to Safely Administer a Highly Active Regimen in Clinical Practice 65
Valutazione farmacocinetica della perfusione pelvica ipossica nel trattamento di pazienti con recidiva non resecabile da carcinoma del retto. 65
Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutation 65
Prognostic relevance of KRAS genotype in metastatic colorectal cancer patients unfit for FIr-B/FOx intensive regimen 65
Carcinoma della vescica 64
Pharmacokinetics in pelvic stop-flow infusion and hypoxic pelvic perfusion with and without hemofiltration. 64
Prognosis of gastric cancer by p53 gene mutations from "touch preparations" and PCR/SSCP analysis. 64
High sensitivity of detectionof TP53 somatic mutations by fluorescence-assisted mismatch analysis 64
Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: a dose-finding study 63
Reducing breast cancer incidence in familial breast cancer: overlooking the present panorama 63
Intraperitoneal chemotherapy [LA CHEMIOTERAPIA INTRAPERITONEALE] 63
Efficacy of treatment with tetracyclines to prevent acneiform eruption secondary to cetuximab therapy 63
Differential prognosis of metastatic colorectal cancer patients post-progression to first-line triplet chemotherapy plus bevacizumab, Fir-B/FOx, according to seconde-line treatment and KRAS genotype 63
Clinical guidelines for the management of gastrointestinal stromal tumors 63
Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients 63
Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: a dose-finding and phase II study 63
Sleep Disturbances in Patients with Advanced Cancer in Different Palliative Care Settings. 62
Familiarity and heredity of tumors in function of an early surgical therapeutic approach 62
Oxaliplatin:preclinical in vitro studies 62
Choice of chemotherapy schedules in elderly patients (> 75 years) with metastatic colorectal cancer (mcrc) according to comorbidity 62
Recidive loco-regionali da carcinoma colo-rettale: risultati a breve termine della perfusione pelvica ipossica. 62
Timed-flat infusion of 5-fluorouracil associated with docetaxel as first-line treatment of patients with metastatic breast cancer 61
Physical Exercise and Quality of Life in Breast Cancer Survivors 61
Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies. 61
Effectiveness and safety of intensive triplet chemotherapy plus bevecizumab, FIr-B/FOx, in young-elderly metastatic colorectal cancer 61
Tamoxifen and breast cancer: is everything known already? 61
Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain-Barré Syndrome 61
Totale 7.463
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.109
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.109
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.413 0 0 185 15 8 212 391 43 248 52 10 249
2020/20211.950 39 247 10 249 243 57 253 25 280 64 382 101
2021/20221.333 57 115 223 68 62 24 26 91 85 33 105 444
2022/20234.568 315 300 71 492 444 471 4 298 1.943 21 125 84
2023/20241.080 151 56 49 126 75 297 11 97 2 46 35 135
2024/2025608 120 87 401 0 0 0 0 0 0 0 0 0
Totale 13.918